These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 28987938)

  • 1. TCB-2 [(7R)-3-bromo-2, 5-dimethoxy-bicyclo[4.2.0]octa-1,3,5-trien-7-yl]methanamine]: A hallucinogenic drug, a selective 5-HT
    Di Giovanni G; De Deurwaerdère P
    Neuropharmacology; 2018 Nov; 142():20-29. PubMed ID: 28987938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a hallucinogenic serotonin 5-HT
    Zhang G; Cinalli D; Stackman RW
    Hippocampus; 2017 May; 27(5):558-569. PubMed ID: 28176400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.
    McLean TH; Parrish JC; Braden MR; Marona-Lewicka D; Gallardo-Godoy A; Nichols DE
    J Med Chem; 2006 Sep; 49(19):5794-803. PubMed ID: 16970404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.
    Takaba R; Ibi D; Yoshida K; Hosomi E; Kawase R; Kitagawa H; Goto H; Achiwa M; Mizutani K; Maeda K; González-Maeso J; Kitagaki S; Hiramatsu M
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3019-3035. PubMed ID: 37874338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes.
    Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K
    Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hallucinogens and Serotonin 5-HT
    López-Giménez JF; González-Maeso J
    Curr Top Behav Neurosci; 2018; 36():45-73. PubMed ID: 28677096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological Mechanism of the Non-hallucinogenic 5-HT
    Cunningham MJ; Bock HA; Serrano IC; Bechand B; Vidyadhara DJ; Bonniwell EM; Lankri D; Duggan P; Nazarova AL; Cao AB; Calkins MM; Khirsariya P; Hwu C; Katritch V; Chandra SS; McCorvy JD; Sames D
    ACS Chem Neurosci; 2023 Jan; 14(1):119-135. PubMed ID: 36521179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Chronic Treatment With 5-HT
    Tsybko AS; Ilchibaeva TV; Filimonova EA; Eremin DV; Popova NK; Naumenko VS
    Neurochem Res; 2020 Dec; 45(12):3059-3075. PubMed ID: 33095437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT
    Gao J; Chen L; Li M
    Pharmacol Biochem Behav; 2019 May; 180():32-43. PubMed ID: 30904543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
    Rickli A; Moning OD; Hoener MC; Liechti ME
    Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonergic hallucinogens differentially modify gamma and high frequency oscillations in the rat nucleus accumbens.
    Goda SA; Piasecka J; Olszewski M; Kasicki S; Hunt MJ
    Psychopharmacology (Berl); 2013 Jul; 228(2):271-82. PubMed ID: 23525524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of 5-HT
    Sánchez-Brualla I; Boulenguez P; Brocard C; Liabeuf S; Viallat-Lieutaud A; Navarro X; Udina E; Brocard F
    Neuroscience; 2018 Sep; 387():48-57. PubMed ID: 28844001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.
    Halberstadt AL; Powell SB; Geyer MA
    Neuropharmacology; 2013 Jul; 70():218-27. PubMed ID: 23376711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis.
    Fox MA; French HT; LaPorte JL; Blackler AR; Murphy DL
    Psychopharmacology (Berl); 2010 Sep; 212(1):13-23. PubMed ID: 19823806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin 5-HT
    Gao J; Nie L; Li Y; Li M
    Neuropharmacology; 2020 Jan; 162():107848. PubMed ID: 31706992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.
    Hagsäter SM; Pettersson R; Pettersson C; Atanasovski D; Näslund J; Eriksson E
    Int J Neuropsychopharmacol; 2021 Sep; 24(9):749-757. PubMed ID: 34228806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
    Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
    Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740.
    Marek GJ; Wright RA; Schoepp DD
    Neurosci Lett; 2006 Aug; 403(3):256-60. PubMed ID: 16759803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.
    Monte AP; Waldman SR; Marona-Lewicka D; Wainscott DB; Nelson DL; Sanders-Bush E; Nichols DE
    J Med Chem; 1997 Sep; 40(19):2997-3008. PubMed ID: 9301661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.